PEPID's September Newsletter

PEPID's September Newsletter

In This Issue

  • Cancer Cachexia: Debilitating Condition Causing Weight Loss Among Advanced Cancer Patients
  • Paraganglioma: Understanding A Rare Tumor Growth
  • PEPID Content: New & Updated?Evidence-based Content in PEPID Suites
  • Blog Post Highlight:?Insulin's Rising Costs: A Barrier to Diabetes Care


Cancer Cachexia: Debilitating Condition Causing Weight Loss Among Advanced Cancer Patients

Cancer cachexia is a complex and debilitating condition often occurring in up to 80% of patients with advanced cancer. It is characterized by a severe wasting of muscle and fat tissue, leading to significant weight loss, weakness, and fatigue. Cancer cachexia can profoundly affect a person's quality of life, making it challenging to tolerate cancer treatments and impairing overall well-being. Despite its prevalence, cancer cachexia remains underrecognized and undertreated in many cases. Understanding and managing cancer cachexia is essential in providing comprehensive care to cancer patients. To gain comprehensive insights into this condition, including its mechanisms, symptoms, and potential interventions, explore the dedicated monograph on PEPID's platform.

Check Out The Cancer Cachexia Monograph


Paraganglioma: Understanding A Rare Tumor Growth

Paraganglioma is a rare but complex tumor that arises in the paraganglia, clusters of cells associated with the autonomic nervous system. These tumors can develop in various locations in the body, often in the head, neck, or abdomen. Paragangliomas may be noncancerous (benign) or cancerous (malignant), and their symptoms can vary depending on their size and location. While some paragangliomas remain asymptomatic, others can cause high blood pressure, rapid heart rate, and other neuroendocrine symptoms. Early diagnosis and appropriate treatment are crucial for managing paragangliomas effectively. To gain comprehensive insights into this condition, including its causes, symptoms, and treatment options, explore the dedicated monograph on PEPID's platform.

Check Out The Paraganglioma Monograph


New & Updated PEPID Content?

Clinical Topics?

  • Alpha-Gal Syndrome
  • Leprosy
  • Femoral Shaft Fracture
  • Lassa Fever
  • Auto-Brewery Syndrome
  • Squamous Cell Carcinoma of Skin
  • Cancer Cachexia
  • Paraganglioma
  • ...and more

New/Updated Drugs

  • Donislecel
  • Nirsevimab
  • Quizartinib
  • Fezolinetant
  • Rozanolixizumab
  • Valoctocogene Roxaparvovec
  • Sulbactam/Durlobactam

Updated Medical Calculators

  • Wound Closure Classification
  • Burch-Wartofsky Point Scale (BWPS) for Thyrotoxicosis
  • Revised Tokuhashi Scoring System
  • Primary Care PTSD Screen for DSM-5 (PC-PTSD-5)
  • PHASES Score
  • HACOR Score
  • G8 Geriatric Screening Tool
  • Current Opioid Misuse Measure (COMM)
  • Canadian Transient Ischemic Attack (TIA) Score
  • Hurt Insult Threaten Scream (HITS) Score


The Robot Will See You Now… How AI & Robotics are Transforming the Healthcare Industry

Experience the future of healthcare with our latest blog post, "Robots in Healthcare: Transforming the Way We Care." Explore how AI and robotics are reshaping medical practices, from diagnosis to rehabilitation. Learn about the remarkable benefits, including precision, efficiency, and safety enhancements, as robots take on tasks like surgeries, medication administration, and patient support. Discover the challenges facing this evolving field, from high costs to ethical considerations. Join us as we delve into the promise of robotics in healthcare and the potential for personalized treatments, robotic surgery, remote healthcare, and improved elderly care. Dive into the future with us on PEPID Pulse.

Get The Inside Scoop

要查看或添加评论,请登录

PEPID的更多文章

社区洞察

其他会员也浏览了